{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T06:03:40Z","timestamp":1778825020098,"version":"3.51.4"},"reference-count":62,"publisher":"American Medical Association (AMA)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Psychiatry"],"published-print":{"date-parts":[[2019,12,1]]},"DOI":"10.1001\/jamapsychiatry.2019.2516","type":"journal-article","created":{"date-parts":[[2019,9,18]],"date-time":"2019-09-18T15:01:06Z","timestamp":1568818866000},"page":"1305","source":"Crossref","is-referenced-by-count":48,"title":["In Vivo Imaging of Translocator Protein in Long-term Cannabis Users"],"prefix":"10.1001","volume":"76","author":[{"given":"Tania","family":"Da Silva","sequence":"first","affiliation":[{"name":"Research Imaging Centre, Centre for Addiction and Mental Health, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sina","family":"Hafizi","sequence":"additional","affiliation":[{"name":"Research Imaging Centre, Centre for Addiction and Mental Health, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeremy J.","family":"Watts","sequence":"additional","affiliation":[{"name":"Research Imaging Centre, Centre for Addiction and Mental Health, Toronto, Ontario, Canada"},{"name":"Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cynthia Shannon","family":"Weickert","sequence":"additional","affiliation":[{"name":"Schizophrenia Research Laboratory, Neuroscience Research Australia, Randwick, New South Wales, Australia"},{"name":"School of Psychiatry, Faculty of Medicine, University of New South Wales, Sydney, New South Wales, Australia"},{"name":"Department of Neuroscience and Physiology, Upstate Medical University, Syracuse, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey H.","family":"Meyer","sequence":"additional","affiliation":[{"name":"Research Imaging Centre, Centre for Addiction and Mental Health, Toronto, Ontario, Canada"},{"name":"Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada"},{"name":"Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada"},{"name":"Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvain","family":"Houle","sequence":"additional","affiliation":[{"name":"Research Imaging Centre, Centre for Addiction and Mental Health, Toronto, Ontario, Canada"},{"name":"Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada"},{"name":"Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pablo","family":"Rusjan","sequence":"additional","affiliation":[{"name":"Research Imaging Centre, Centre for Addiction and Mental Health, Toronto, Ontario, Canada"},{"name":"Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada"},{"name":"Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Romina","family":"Mizrahi","sequence":"additional","affiliation":[{"name":"Research Imaging Centre, Centre for Addiction and Mental Health, Toronto, Ontario, Canada"},{"name":"Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada"},{"name":"Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada"},{"name":"Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","reference":[{"key":"yoi190058r2","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ypmed.2017.07.008","article-title":"Cannabis use, attitudes, and legal status in the U.S.: a review.","volume":"104","author":"Carliner","year":"2017","journal-title":"Prev Med"},{"issue":"1","key":"yoi190058r3","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/npp.2017.198","article-title":"US epidemiology of cannabis use and associated problems.","volume":"43","author":"Hasin","year":"2018","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"yoi190058r4","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S0163-7258(97)82001-3","article-title":"Pharmacology of cannabinoid CB1 and CB2 receptors.","volume":"74","author":"Pertwee","year":"1997","journal-title":"Pharmacol Ther"},{"issue":"3","key":"yoi190058r5","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/0165-0173(94)00015-H","article-title":"Microglia: intrinsic immuneffector cell of the brain.","volume":"20","author":"Gehrmann","year":"1995","journal-title":"Brain Res Brain Res Rev"},{"issue":"8","key":"yoi190058r6","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/0166-2236(96)10049-7","article-title":"Microglia: a sensor for pathological events in the CNS.","volume":"19","author":"Kreutzberg","year":"1996","journal-title":"Trends Neurosci"},{"key":"yoi190058r7","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.pharmthera.2016.06.011","article-title":"Microglia activation states and cannabinoid system: therapeutic implications.","volume":"166","author":"Mecha","year":"2016","journal-title":"Pharmacol Ther"},{"key":"yoi190058r8","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.bbi.2014.01.018","article-title":"Immune system: a possible nexus between cannabinoids and psychosis.","volume":"40","author":"Su\u00e1rez-Pinilla","year":"2014","journal-title":"Brain Behav Immun"},{"issue":"4","key":"yoi190058r9","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1016\/j.neuroscience.2006.11.016","article-title":"Anti-inflammatory property of the cannabinoid agonist WIN-55212-2 in a rodent model of chronic brain inflammation.","volume":"144","author":"Marchalant","year":"2007","journal-title":"Neuroscience"},{"issue":"6","key":"yoi190058r10","doi-asserted-by":"publisher","first-page":"e331","DOI":"10.1038\/cddis.2012.71","article-title":"Cannabidiol protects oligodendrocyte progenitor cells from inflammation-induced apoptosis by attenuating endoplasmic reticulum stress.","volume":"3","author":"Mecha","year":"2012","journal-title":"Cell Death Dis"},{"key":"yoi190058r11","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.nbd.2013.06.016","article-title":"Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: a role for A2A receptors.","volume":"59","author":"Mecha","year":"2013","journal-title":"Neurobiol Dis"},{"issue":"5","key":"yoi190058r12","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/sj.bjp.0707458","article-title":"Cannabinoid control of neuroinflammation related to multiple sclerosis.","volume":"152","author":"Baker","year":"2007","journal-title":"Br J Pharmacol"},{"issue":"5","key":"yoi190058r13","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1038\/sj.bjp.0707433","article-title":"Endocannabinoid metabolism and uptake: novel targets for neuropathic and inflammatory pain.","volume":"152","author":"Jhaveri","year":"2007","journal-title":"Br J Pharmacol"},{"issue":"3","key":"yoi190058r14","doi-asserted-by":"publisher","first-page":"187","DOI":"10.2165\/11539000-000000000-00000","article-title":"Role of cannabinoids in multiple sclerosis.","volume":"25","author":"Zajicek","year":"2011","journal-title":"CNS Drugs"},{"issue":"3","key":"yoi190058r15","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1111\/j.1476-5381.2010.00756.x","article-title":"The plant cannabinoid ?9-tetrahydrocannabivarin can decrease signs of inflammation and inflammatory pain in mice.","volume":"160","author":"Bolognini","year":"2010","journal-title":"Br J Pharmacol"},{"issue":"6","key":"yoi190058r16","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1111\/j.1476-5381.2011.01673.x","article-title":"Cannabinoid CB(2) receptors modulate ERK-1\/2 kinase signalling and NO release in microglial cells stimulated with bacterial lipopolysaccharide","volume":"165","author":"Merighi","year":"2012","journal-title":"Br J Pharmacol"},{"issue":"1","key":"yoi190058r17","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1002\/(ISSN)1098-1136","article-title":"Cannabinoids inhibit LPS-inducible cytokine mRNA expression in rat microglial cells.","volume":"29","author":"Puffenbarger","year":"2000","journal-title":"Glia"},{"issue":"16","key":"yoi190058r18","doi-asserted-by":"publisher","first-page":"6470","DOI":"10.1523\/JNEUROSCI.23-16-06470.2003","article-title":"Endogenous interleukin-1 receptor antagonist mediates anti-inflammatory and neuroprotective actions of cannabinoids in neurons and glia.","volume":"23","author":"Molina-Holgado","year":"2003","journal-title":"J Neurosci"},{"issue":"1","key":"yoi190058r20","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1026\/\/0012-1924.45.1.8","article-title":"The Trier Inventory for the Assessment of Chronic Stress (TICS): scale construction, statistical testing, and validation of the scale work overload.","volume":"45","author":"Schulz","year":"1999","journal-title":"Diagnostica"},{"issue":"6","key":"yoi190058r21","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1037\/0022-006X.56.6.893","article-title":"An inventory for measuring clinical anxiety: psychometric properties.","volume":"56","author":"Beck","year":"1988","journal-title":"J Consult Clin Psychol"},{"issue":"1-3","key":"yoi190058r22","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.drugalcdep.2008.12.010","article-title":"Reliability and validity of a short form of the Marijuana Craving Questionnaire.","volume":"102","author":"Heishman","year":"2009","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"yoi190058r23","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.drugalcdep.2005.10.014","article-title":"The Severity of Dependence Scale (SDS) in an adolescent population of cannabis users: reliability, validity and diagnostic cut-off.","volume":"83","author":"Martin","year":"2006","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"yoi190058r24","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1176\/appi.ajp.2016.16020171","article-title":"Imaging microglial activation in untreated first-episode psychosis: a PET study with [18F] FEPPA.","volume":"174","author":"Hafizi","year":"2017","journal-title":"Am J Psychiatry"},{"issue":"1","key":"yoi190058r25","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1093\/schbul\/sbu157","article-title":"Imaging neuroinflammation in gray and white matter in schizophrenia: an in-vivo PET study with [18F]-FEPPA.","volume":"41","author":"Kenk","year":"2015","journal-title":"Schizophr Bull"},{"issue":"6","key":"yoi190058r26","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1038\/jcbfm.2012.46","article-title":"Translocator protein (18?kDa) polymorphism (rs6971) explains in-vivo brain binding affinity of the PET radioligand [(18)F]-FEPPA.","volume":"32","author":"Mizrahi","year":"2012","journal-title":"J Cereb Blood Flow Metab"},{"issue":"3","key":"yoi190058r27","doi-asserted-by":"publisher","first-page":"237","DOI":"10.9758\/cpn.2017.15.3.237","article-title":"Evaluation of oxidant\/antioxidant status and cytokine levels in patients with cannabis use disorder.","volume":"15","author":"Bayazit","year":"2017","journal-title":"Clin Psychopharmacol Neurosci"},{"issue":"7","key":"yoi190058r28","doi-asserted-by":"publisher","first-page":"2816","DOI":"10.1172\/JCI67569","article-title":"Microglial activation underlies cerebellar deficits produced by repeated cannabis exposure.","volume":"123","author":"Cutando","year":"2013","journal-title":"J Clin Invest"},{"issue":"2","key":"yoi190058r29","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1111\/adb.12116","article-title":"[18F]MK-9470 PET measurement of cannabinoid CB1 receptor availability in chronic cannabis users.","volume":"20","author":"Ceccarini","year":"2015","journal-title":"Addict Biol"},{"issue":"1","key":"yoi190058r30","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.bpsc.2015.09.008","article-title":"Rapid changes in CB1 receptor availability in cannabis dependent males after abstinence from cannabis.","volume":"1","author":"D\u2019Souza","year":"2016","journal-title":"Biol Psychiatry Cogn Neurosci Neuroimaging"},{"issue":"6","key":"yoi190058r31","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1038\/mp.2011.82","article-title":"Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokers.","volume":"17","author":"Hirvonen","year":"2012","journal-title":"Mol Psychiatry"},{"issue":"2","key":"yoi190058r32","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s11481-015-9592-2","article-title":"Exposure of adolescent mice to delta-9-tetrahydrocannabinol induces long-lasting modulation of pro-and anti-inflammatory cytokines in hypothalamus and hippocampus similar to that observed for peripheral macrophages.","volume":"10","author":"Moretti","year":"2015","journal-title":"J Neuroimmune Pharmacol"},{"issue":"12","key":"yoi190058r33","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1016\/j.euroneuro.2015.09.021","article-title":"Cortical neuroinflammation contributes to long-term cognitive dysfunctions following adolescent delta-9-tetrahydrocannabinol treatment in female rats.","volume":"25","author":"Zamberletti","year":"2015","journal-title":"Eur Neuropsychopharmacol"},{"key":"yoi190058r34","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.neuropharm.2017.03.033","article-title":"New vistas on cannabis use disorder.","volume":"124","author":"Melis","year":"2017","journal-title":"Neuropharmacology"},{"issue":"2","key":"yoi190058r35","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s40429-017-0143-1","article-title":"Cannabis withdrawal: a review of neurobiological mechanisms and sex differences.","volume":"4","author":"Schlienz","year":"2017","journal-title":"Curr Addict Rep"},{"issue":"9","key":"yoi190058r36","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1038\/nm.4397","article-title":"Microglia emerge as central players in brain disease.","volume":"23","author":"Salter","year":"2017","journal-title":"Nat Med"},{"key":"yoi190058r37","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.pnpbp.2013.11.017","article-title":"Role of the endocannabinoid system in brain functions relevant for schizophrenia: an overview of human challenge studies with cannabis or ?9-tetrahydrocannabinol (THC).","volume":"52","author":"Bossong","year":"2014","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"yoi190058r38","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.neuropharm.2017.04.018","article-title":"Mechanisms contributing to cognitive deficits in cannabis users.","volume":"124","author":"Mizrahi","year":"2017","journal-title":"Neuropharmacology"},{"issue":"3","key":"yoi190058r39","doi-asserted-by":"publisher","first-page":"e22020","DOI":"10.1002\/syn.v72.3","article-title":"THC alters morphology of neurons in medial prefrontal cortex, orbital prefrontal cortex, and nucleus accumbens and alters the ability of later experience to promote structural plasticity.","volume":"72","author":"Kolb","year":"2018","journal-title":"Synapse"},{"issue":"4","key":"yoi190058r40","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/s41380-018-0243-x","article-title":"Adolescent exposure to ?9-tetrahydrocannabinol alters the transcriptional trajectory and dendritic architecture of prefrontal pyramidal neurons.","volume":"24","author":"Miller","year":"2019","journal-title":"Mol Psychiatry"},{"issue":"3","key":"yoi190058r41","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1038\/s41593-018-0334-7","article-title":"Increased synapse elimination by microglia in schizophrenia patient-derived models of synaptic pruning.","volume":"22","author":"Sellgren","year":"2019","journal-title":"Nat Neurosci"},{"issue":"4","key":"yoi190058r42","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.neuron.2012.03.026","article-title":"Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner.","volume":"74","author":"Schafer","year":"2012","journal-title":"Neuron"},{"issue":"2","key":"yoi190058r43","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/mp.2016.248","article-title":"Translational evaluation of translocator protein as a marker of neuroinflammation in schizophrenia.","volume":"23","author":"Notter","year":"2018","journal-title":"Mol Psychiatry"},{"issue":"4","key":"yoi190058r44","doi-asserted-by":"publisher","first-page":"e777","DOI":"10.1038\/tp.2016.40","article-title":"In vivo markers of inflammatory response in recent-onset schizophrenia: a combined study using [(11)C]DPA-713 PET and analysis of CSF and plasma.","volume":"6","author":"Coughlin","year":"2016","journal-title":"Transl Psychiatry"},{"issue":"3","key":"yoi190058r45","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1001\/jamapsychiatry.2014.2427","article-title":"Role of translocator protein density, a marker of neuroinflammation, in the brain during major depressive episodes.","volume":"72","author":"Setiawan","year":"2015","journal-title":"JAMA Psychiatry"},{"issue":"8","key":"yoi190058r46","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1093\/jat\/29.8.842","article-title":"THC can be detected in brain while absent in blood.","volume":"29","author":"Mura","year":"2005","journal-title":"J Anal Toxicol"},{"key":"yoi190058r47","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.neuropharm.2017.06.023","article-title":"Overexpression of the 18 kDa translocator protein (TSPO) in the hippocampal dentate gyrus produced anxiolytic and antidepressant-like behavioural effects.","volume":"125","author":"Li","year":"2017","journal-title":"Neuropharmacology"},{"issue":"1","key":"yoi190058r48","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13550-018-0401-9","article-title":"PET radioligand binding to translocator protein (TSPO) is increased in unmedicated depressed subjects.","volume":"8","author":"Richards","year":"2018","journal-title":"EJNMMI Res"},{"issue":"8","key":"yoi190058r49","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1001\/jamapsychiatry.2017.1567","article-title":"Inflammation in the neurocircuitry of obsessive-compulsive disorder.","volume":"74","author":"Attwells","year":"2017","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"yoi190058r50","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.bbi.2006.03.005","article-title":"Microglia serve as a neuroimmune substrate for stress-induced potentiation of CNS pro-inflammatory cytokine responses.","volume":"21","author":"Frank","year":"2007","journal-title":"Brain Behav Immun"},{"issue":"1-2","key":"yoi190058r51","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.jneuroim.2005.09.012","article-title":"Stress-induced elevation of glucocorticoids increases microglia proliferation through NMDA receptor activation.","volume":"171","author":"Nair","year":"2006","journal-title":"J Neuroimmunol"},{"issue":"1-2","key":"yoi190058r52","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.brainres.2003.08.006","article-title":"Peripheral and central proinflammatory cytokine response to a severe acute stressor.","volume":"991","author":"O\u2019Connor","year":"2003","journal-title":"Brain Res"},{"issue":"3","key":"yoi190058r53","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/j.neuroscience.2007.02.043","article-title":"Stress induced morphological microglial activation in the rodent brain: involvement of interleukin-18.","volume":"146","author":"Sugama","year":"2007","journal-title":"Neuroscience"},{"issue":"7","key":"yoi190058r54","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1016\/j.bbi.2010.02.001","article-title":"Chronic stress alters the density and morphology of microglia in a subset of stress-responsive brain regions.","volume":"24","author":"Tynan","year":"2010","journal-title":"Brain Behav Immun"},{"issue":"17","key":"yoi190058r55","doi-asserted-by":"publisher","first-page":"6277","DOI":"10.1523\/JNEUROSCI.0450-11.2011","article-title":"\u00df-adrenergic receptor antagonism prevents anxiety-like behavior and microglial reactivity induced by repeated social defeat.","volume":"31","author":"Wohleb","year":"2011","journal-title":"J Neurosci"},{"issue":"9","key":"yoi190058r56","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1016\/j.pain.2014.05.031","article-title":"Suppression of bone marrow-derived microglia in the amygdala improves anxiety-like behavior induced by chronic partial sciatic nerve ligation in mice.","volume":"155","author":"Sawada","year":"2014","journal-title":"Pain"},{"issue":"7","key":"yoi190058r57","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1177\/0271678X17712388","article-title":"Kinetic modelling of [11C] PBR28 for 18 kDa translocator protein PET data: a validation study of vascular modelling in the brain using XBD173 and tissue analysis.","volume":"38","author":"Veronese","year":"2018","journal-title":"J Cereb Blood Flow Metab"},{"issue":"9","key":"yoi190058r58","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1038\/s41386-018-0085-x","article-title":"Influence of alcoholism and cholesterol on TSPO binding in brain: PET [11C]PBR28 studies in humans and rodents.","volume":"43","author":"Kim","year":"2018","journal-title":"Neuropsychopharmacology"},{"issue":"8","key":"yoi190058r59","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1038\/npp.2017.48","article-title":"Effect of cigarette smoking on a marker for neuroinflammation: a [11C]DAA1106 positron emission tomography study.","volume":"42","author":"Brody","year":"2017","journal-title":"Neuropsychopharmacology"},{"issue":"8-9","key":"yoi190058r60","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.lfs.2012.06.009","article-title":"Sex differences in cannabinoid pharmacology: a reflection of differences in the endocannabinoid system?","volume":"92","author":"Craft","year":"2013","journal-title":"Life Sci"},{"issue":"4","key":"yoi190058r61","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s40473-018-0167-4","article-title":"Cannabis use: neurobiological, behavioral, and sex\/gender considerations.","volume":"5","author":"Nia","year":"2018","journal-title":"Curr Behav Neurosci Rep"},{"key":"yoi190058r62","doi-asserted-by":"publisher","first-page":"249","DOI":"10.3389\/fnbeh.2018.00249","article-title":"The modulating role of sex and anabolic-androgenic steroid hormones in cannabinoid sensitivity.","volume":"12","author":"Struik","year":"2018","journal-title":"Front Behav Neurosci"},{"key":"yoi190058r19","volume-title":"Structured Clinical Interview for DSM-IV-TR Axis I Disorders. Research Version; Patient Edition","author":"First","year":"2002"},{"key":"yoi190058r1","unstructured":"United Nations Office on Drugs and Crime. World Drug Report2018. https:\/\/www.unodc.org\/wdr2018\/prelaunch\/WDR18_Booklet_1_EXSUM.pdf. Published June 2018. Accessed February 19, 2019."}],"container-title":["JAMA Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamapsychiatry\/articlepdf\/2751262\/jamapsychiatry_da_silva_2019_oi_190058.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,4]],"date-time":"2019-12-04T16:01:48Z","timestamp":1575475308000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamapsychiatry\/fullarticle\/2751262"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,1]]},"references-count":62,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,12,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamapsychiatry.2019.2516","relation":{},"ISSN":["2168-622X"],"issn-type":[{"value":"2168-622X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12,1]]}}}